Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
02:15pm, Tuesday, 07'th Jul 2026
Eli Lilly and Intuitive Surgical are top players in their respective corners of the healthcare market. Both companies are highly innovative and boast attractive long-term growth opportunities.
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
01:15pm, Tuesday, 07'th Jul 2026
Eli Lilly shares hit a record high Tuesday after IPO stock Kailera Therapeutics posted lackluster test results for its weight-loss pill.
Jim Cramer Calls Biotech “The Hottest Group in the Market” as He Predicts “Deals Are Going to Be Flooding the Market”
12:30pm, Tuesday, 07'th Jul 2026
On CNBC's Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing that the sector could be entering a new wave of mergers and acquisitions as
Is It Too Late to Buy Eli Lilly Stock? Here's What $1,000 Invested Today Could Be Worth in 10 Years.
08:10am, Tuesday, 07'th Jul 2026
The obesity drug industry is likely a decade-long tailwind for Eli Lilly's business. Foundayo and Retatrutide could cement a decade of growth.
Eli Lilly (LLY) Stock Slides as Market Rises: Facts to Know Before You Trade
06:46pm, Monday, 06'th Jul 2026
In the closing of the recent trading day, Eli Lilly (LLY) stood at $1, denoting a -1.14% move from the preceding trading day.
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
10:01am, Monday, 06'th Jul 2026
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dividend King vs. Growth Giant: Johnson & Johnson Takes on Eli Lilly
02:00pm, Saturday, 04'th Jul 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) and Johnson & Johnson (NYSE:JNJ) just reported Q1 2026 results that read like two different playbooks for winning in healthcare.
Eli Lilly Price Prediction: The Case for Double-Digit Upside
01:18pm, Wednesday, 01'st Jul 2026
Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43.
Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China
01:09pm, Wednesday, 01'st Jul 2026
Innovent Biologics, Inc. and Eli Lilly and Co. (NYSE:LLY) on Tuesday entered into a distribution and promotion agreement for Eli Lilly's breast cancer therapy Verzenios (abemaciclib) in mainland China
New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks
11:50am, Wednesday, 01'st Jul 2026
If you sort all the top politicians with a portfolio of above $1 million using their annual gains, who do you expect at the top? Likely Nancy Pelosi, but that's not the case. A Republican Senator name
Eli Lilly Hands China Sales Rights for Verzenio to Innovent
12:02pm, Tuesday, 30'th Jun 2026
Eli Lilly (LLY, Financials) is turning to Innovent Biologics to handle sales of Verzenio in mainland China. The breast cancer drug has been available there sinc
Merck, AbbVie probed by US lawmakers over China clinical trials: report
08:19am, Tuesday, 30'th Jun 2026
A bipartisan group of United States lawmakers has opened national security investigations into whether five major pharmaceutical companies, including Merck...
Eli Lilly Expands China Cancer Reach
07:14am, Tuesday, 30'th Jun 2026
Eli Lilly (LLY) is expanding its China oncology reach through a new commercialization agreement with Innovent Biologics for Verzenios.Under the deal, Innovent w
Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow
05:06am, Tuesday, 30'th Jun 2026
Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a handful of bargains and pretenders.
Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder
04:02am, Tuesday, 30'th Jun 2026
Eli Lilly is leveraging its exceptional cash flow to build an AI-native drug discovery and manufacturing platform, transforming its equity narrative beyond weight loss drugs. LLY's financial momentum
